Ursolic acid, a compound from traditional Chinese medicine, significantly reduced liver fat, inflammation, and scarring in mice with diet-induced fatty liver disease by blocking a harmful molecular pathway called NOX4/ROS/NLRP3. According to Gram Research analysis, this 2026 animal study suggests ursolic acid could become a new treatment for metabolic dysfunction-associated fatty liver disease in humans, though clinical trials are needed to confirm safety and effectiveness.
Researchers discovered that ursolic acid, a compound found in traditional Chinese medicine, may help treat metabolic dysfunction-associated fatty liver disease (MAFLD), a serious condition where fat builds up in the liver. In a study using mice, ursolic acid reduced liver fat, inflammation, and scarring by blocking a harmful chain reaction involving molecules called NOX4, ROS, and NLRP3. According to Gram Research analysis, this finding suggests a promising new treatment approach for people with fatty liver disease, though human studies are still needed to confirm these results.
Key Statistics
A 2026 animal study found that ursolic acid treatment reduced liver fat deposition, inflammation markers (TNF-alpha, IL-1 beta, and IL-6), and fibrosis-related proteins in mice fed a high-fat diet for 24 weeks.
Ursolic acid treatment significantly decreased levels of NOX4, ROS, and NLRP3 in high-fat diet-fed mice, with similar improvements observed in genetically modified mice lacking NLRP3 or treated with Apocynin, confirming the importance of this molecular pathway.
Mice treated with ursolic acid showed improved glucose tolerance and insulin tolerance alongside reductions in liver enzymes and triglycerides, suggesting benefits extending beyond liver fat reduction.
The Quick Take
- What they studied: Whether a natural compound called ursolic acid could treat fatty liver disease by blocking a specific harmful pathway in the body
- Who participated: Laboratory mice, including normal mice and genetically modified mice lacking certain proteins, fed either normal or high-fat diets for 24 weeks
- Key finding: Ursolic acid treatment significantly reduced liver fat, inflammation markers, and liver scarring in mice with diet-induced fatty liver disease
- What it means for you: This research suggests ursolic acid might become a new treatment for fatty liver disease in humans, but clinical trials in people are needed before it can be recommended as a therapy
The Research Details
Scientists conducted an animal study using mice to test whether ursolic acid could treat fatty liver disease. They divided mice into different groups: some were genetically modified to lack specific proteins involved in inflammation, while others received a drug called Apocynin that blocks part of the harmful pathway. All mice were fed either a normal diet or a high-fat diet for 24 weeks, and some groups received ursolic acid treatment for the final 6 weeks.
The researchers measured multiple outcomes including liver weight, liver enzymes in the blood, fat levels, inflammation markers, and genes related to fat storage and liver scarring. They used several laboratory techniques including blood tests, tissue examination under a microscope, and genetic analysis to track changes in the liver.
This approach allowed researchers to understand not just whether ursolic acid worked, but also which specific molecular pathway was responsible for its effects. By testing mice lacking certain proteins, they could confirm that blocking the NOX4/ROS/NLRP3 pathway was key to the treatment’s benefits.
Using animal models allows researchers to test potential treatments safely and understand the biological mechanisms before moving to human trials. The study design with genetically modified mice helps identify exactly which molecular pathways are responsible for the benefits, making it easier to develop more targeted treatments in the future.
This study has several strengths: it used multiple types of mice to confirm the mechanism, measured many different outcomes related to liver health, and used established laboratory techniques. However, this is animal research, so results may not directly translate to humans. The study did not specify the exact number of mice used in each group, which makes it harder to assess statistical power. Published in a peer-reviewed journal, this work represents solid preliminary evidence but requires human clinical trials for confirmation.
What the Results Show
Ursolic acid treatment produced significant improvements in mice with diet-induced fatty liver disease. Treated mice showed reduced body weight, lower liver enzymes (indicating less liver damage), decreased triglycerides (a type of fat in the blood), and less fat accumulation in liver tissue compared to untreated mice on the same high-fat diet.
The compound also reduced inflammation throughout the liver by decreasing levels of inflammatory proteins including TNF-alpha, IL-1 beta, and IL-6. Additionally, ursolic acid improved how well the mice’s bodies handled glucose and responded to insulin, suggesting benefits beyond just the liver.
Liver scarring, a serious complication of fatty liver disease, was also reduced in ursolic acid-treated mice. Markers of fibrosis (scarring), including alpha-SMA, collagen-1, and TIMP-1, all decreased significantly with treatment.
The study confirmed that ursolic acid worked by blocking the NOX4/ROS/NLRP3 pathway. Levels of NOX4 (an enzyme that produces harmful molecules), ROS (reactive oxygen species, which are damaging molecules), and NLRP3 (an inflammation-triggering protein) were all significantly reduced in treated mice.
The research also showed that ursolic acid reduced the expression of genes involved in fat storage and production, including FAS, SREBP1, and ACC1. This suggests the compound helps the liver produce less new fat and may improve how the body processes existing fat. Mice lacking the NLRP3 protein or treated with Apocynin (which blocks part of the pathway) showed similar improvements even without ursolic acid, confirming that this pathway is central to the treatment effect.
Fatty liver disease has been a growing health problem with limited treatment options. Previous research identified the NOX4/ROS/NLRP3 pathway as important in liver inflammation and damage. This study is among the first to show that ursolic acid, a traditional medicine compound, can specifically target this pathway. The findings align with other research showing that blocking inflammation and oxidative stress (cellular damage from harmful molecules) can improve fatty liver disease.
This research was conducted entirely in mice, and animal studies do not always produce the same results in humans. The study did not specify how many mice were used in each group, making it difficult to assess whether the sample size was adequate. The duration of treatment in mice (6 weeks) is relatively short compared to the chronic nature of human fatty liver disease. Additionally, the study did not compare ursolic acid to existing treatments or examine potential side effects in detail. Human clinical trials are necessary before ursolic acid can be recommended as a therapy.
The Bottom Line
Based on this animal research, ursolic acid shows promise as a potential treatment for fatty liver disease by reducing fat accumulation, inflammation, and scarring. However, human clinical trials are needed before any recommendations can be made. People with fatty liver disease should continue following their doctor’s advice regarding diet, exercise, and any prescribed medications. Do not self-treat with ursolic acid supplements without consulting a healthcare provider, as safety and effectiveness in humans have not been established.
This research is most relevant to people with metabolic dysfunction-associated fatty liver disease (MAFLD), formerly called non-alcoholic fatty liver disease. It may also interest researchers developing new treatments for liver disease and healthcare providers looking for novel therapeutic approaches. People with obesity, type 2 diabetes, or metabolic syndrome should be aware of this emerging research, as these conditions increase fatty liver disease risk.
In the mouse study, significant improvements appeared within 6 weeks of ursolic acid treatment. If human trials proceed, it typically takes 5 to 10 years to move from animal studies to approved medications. Realistic expectations would involve waiting for clinical trial results before any treatment becomes available.
Frequently Asked Questions
What is ursolic acid and where does it come from?
Ursolic acid is a natural compound found in traditional Chinese medicine and certain plants. In this 2026 study, researchers tested whether it could treat fatty liver disease by blocking harmful molecular pathways that cause liver inflammation and fat accumulation.
Can I take ursolic acid supplements to treat my fatty liver disease?
Not yet. While this animal study shows promise, human clinical trials have not been completed. Consult your doctor before taking any supplements, as safety and effectiveness in people remain unproven. Current treatment focuses on weight loss, diet changes, and exercise.
How does ursolic acid help the liver?
According to this research, ursolic acid blocks a harmful chain reaction involving NOX4, ROS, and NLRP3 proteins that causes liver inflammation and fat buildup. By stopping this pathway, the compound reduces liver damage, scarring, and improves how the body handles glucose and fat.
When will ursolic acid be available as a treatment for humans?
This animal research is preliminary. Human clinical trials typically take 5 to 10 years to complete. Researchers must first conduct safety studies, then efficacy trials in people with fatty liver disease before any potential approval by regulatory agencies.
Who should be most interested in this fatty liver research?
People with metabolic dysfunction-associated fatty liver disease, obesity, type 2 diabetes, or metabolic syndrome should follow this research. Healthcare providers treating liver disease and pharmaceutical researchers developing new treatments are also key audiences for these findings.
Want to Apply This Research?
- Track liver health markers including weight, waist circumference, and energy levels weekly. If you have access to lab results, monitor liver enzyme levels (ALT and AST) and triglycerides every 3 months to assess liver function changes.
- Use the app to log daily dietary choices focusing on reducing high-fat foods and processed sugars, which worsen fatty liver disease. Set reminders for consistent exercise (150 minutes per week of moderate activity) and track completion to support liver health while waiting for potential new treatments.
- Create a long-term health dashboard tracking weight trends, dietary patterns, exercise consistency, and any available lab results. Set monthly check-ins to review progress and identify patterns between lifestyle choices and how you feel, preparing data to discuss with your doctor about emerging treatments.
This article summarizes animal research on ursolic acid for fatty liver disease. These findings have not been tested in humans, and ursolic acid is not an approved treatment for any liver condition. Do not use ursolic acid supplements to treat fatty liver disease without consulting your healthcare provider. This information is for educational purposes only and should not replace professional medical advice. People with liver disease should work with their doctor to develop an appropriate treatment plan based on established therapies and their individual health needs.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.